COMBINED PARAMETERS IN THE SAME PRODUCT (IV) - NEONATAL SCREENING - ANVISA Registration 80173700033
Access comprehensive regulatory information for COMBINED PARAMETERS IN THE SAME PRODUCT (IV) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80173700033 and manufactured by INTERNACIONAL CIENTÍFICA LTDA. The registration is held by INTERNACIONAL CIENTIFICA LTDA with validity until Dec 18, 2033.
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 1 companies making the same product including INTERNACIONAL CIENTÍFICA LTDA, and 1 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80173700033
25351565461202379
04912061000186
Company Information
Dates and Status
Dec 18, 2023
18/12/2033
09/18/2025 19:00:01
COMBINED PARAMETERS IN THE SAME PRODUCT (IV) - NEONATAL SCREENING
NeoMAP® 3Plex IgM
INTERNACIONAL CIENTÍFICA LTDA
80173700032
Sep 19, 2022
COMBINED PARAMETERS IN THE SAME PRODUCT (III) - NEONATAL SCREENING
O Kit NeoMAP® 4PLEX TSH – T4 – 17OH - IRT
INTERNACIONAL CIENTÍFICA LTDA
80173700014
Apr 11, 2011
COMBINED PARAMETERS IN THE SAME PRODUCT (III) - NEONATAL SCREENING
NeoBase Non-Derivatized MSMS Kit
Not specified
10298910097
Apr 13, 2009
COMBINED PARAMETERS IN THE SAME PRODUCT (III) - NEONATAL SCREENING
NeoBase Non-Derivatized MSMS Kit
WALLAC OY
10298910097
Apr 13, 2009
COMBINED PARAMETERS IN THE SAME PRODUCT (III) - NEONATAL SCREENING
Eonis™ SCID-SMA kit PN 3241-0010/ PN 3242-0010
WALLAC OY
10298910155
May 03, 2021